Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb

Gutscheinbedingungen

*Gültig bis 05.07.2026 auf (fast) alles. Ausgeschlossen sind Smartboxen, Zeitschriften, Tickets, Lebensmittel, Gaming-Elektroartikel, Tinte/Toner, Gutscheine, Geschenkkarten, Blumen und Abos | Einlösbar in allen Buchhandlungen von Orell Füssli, Barth Bücher, Buchladen Rapunzel, Papeterie Köhler, Schuler Orell Füssli, Stauffacher und ZAP unter Vorweisung des Gutscheins, auf www.orellfüssli.ch durch Eingabe des Gutscheincodes. Beim Service „eBooks verschenken“ und bei eBook-Käufen via eReader nicht einlösbar | Mindesteinkaufswert: Fr. 30.- | Nicht mit anderen Rabatten kumulierbar.
  • Produktbild: Investigation and Exploitation of Antibody Combining Sites
  • Produktbild: Investigation and Exploitation of Antibody Combining Sites

Investigation and Exploitation of Antibody Combining Sites

Aus der Reihe Methodological Surveys in Biochemistry and Analysis

Fr. 73.90

inkl. gesetzl. MwSt., Versandkostenfrei

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.11.2012

Abbildungen

175 illus., schwarz-weiss Illustrationen

Verlag

Springer Us

Seitenzahl

359

Maße (L/B/H)

24.4/17/2.1 cm

Gewicht

661 g

Auflage

Softcover reprint of the original 1st ed. 1985

Sprache

Englisch

ISBN

978-1-4684-5008-8

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

25.11.2012

Abbildungen

175 illus., schwarz-weiss Illustrationen

Verlag

Springer Us

Seitenzahl

359

Maße (L/B/H)

24.4/17/2.1 cm

Gewicht

661 g

Auflage

Softcover reprint of the original 1st ed. 1985

Sprache

Englisch

ISBN

978-1-4684-5008-8

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Investigation and Exploitation of Antibody Combining Sites
  • Produktbild: Investigation and Exploitation of Antibody Combining Sites
  • #A Antibody Combining Sites, Especially Structure.- #A–1 Antibody combining sites — past, present and future.- #A–2 Variability, modelling and prediction of ?-hairpins with reference to the immunoglobulin fold.- #A–3 Probing the binding sites in crystals of immunoglobulins.- #A–4 Comparative structures of mouse antibody combining sites.- #NC(A) NOTE and COMMENTS related to the foregoing topics*.- #NC(A)–1 An approach to the study of anti-protein antibody combining sites.- #B Production and Characterization of Antibodies, in Contexts such as Receptor Investigation.- #B–1 Investigating the specificity of monoclonal antibodies to protein antigens using ?-galactosidase fusion proteins.- #B–2 Antibody-screening cDNA libraries.- #B–3 Anti-receptor antibodies by the auto-anti-idiotypic route.- #B–4 Production and characterization of anti-morphine anti-idiotypic antibodies.- #B–5 Anti-idiotype antibodies for the study of membrane receptors: the double monoclonal antibody approach.- #NC(B) NOTES and COMMENTS related to the foregoing topics.- #NC(B)–1 Characterization of idiotypes and VH genes of various members of A48-idiotypic network pathway.- #NC(B)–2 Monoclonal internal image anti-idiotypic antibodies of hepatitis B surface antigen.- #NC(B)–3 Structure and expression of genes encoding IgA heavy chains.- #NC(B)–4 Human:mouse antibody-producing transfectoma cell lines.- #NC(B)–5 Different ways to modify monoclonal antibodies.- #NC(B)–6 Restructuring enzymes and antibodies.- #NC(B)–7 Dideoxy mRNA sequencing as a method to analyze antibody diversity.- #NC(B)–8 Effect of multivalent binding on dissociation of monoclonal antibodies from cell surface antigens.- #C Cytoskeletal, Myocyte and Neuronal Studies with Antibodies.- #C–1 Immunological approaches and techniques employed in tubulin and microtubule research.- #C–2 Cell-surface events during myogenesis: immunofluorescence analysis using monoclonal antibodies.- #C–3 Differential expression of cell-surface antigens on muscle satellite cells and myoblasts.- #C–4 Cholinergic-specific nerve terminal antigens.- #C–5 Use of antibodies to purify cholinergic nerve terminals.- #NC(C) NOTES and COMMENTS related to the foregoing topics.- #NC(C)–1 An immunological approach to the cell lineage problem in the mammalian CNS.- #NC(C)–2 An enzyme-linked immunosorbent assay for calmodulin.- #NC(C)–3 Intermediate filament diversity as detected by antibodies.- #D Antibody Approaches to Membrane Components Including the T-Cell Receptor.- #D–1 Exploitation of antibodies in the study of cell membranes.- #D–2 Use of polyclonal and monoclonal antibodies in studying complement component C9 as a transmembrane protein.- #D–3 Ca2+-binding proteins located on the cytoplasmic face of the lymphocyte plasma membrane.- #D–4 The T-cell receptor.- #NC(D) NOTES and COMMENTS related to the foregoing topics.- #NC(D)–1 New light on the T-cell receptor in relation to antibody binding sites.- #NC(D)–2 Molecular nature of the T3 antigen of human T lymphocytes.- #NC(D)–3 Organization and expression of the murine T-cell receptor ?-chain gene complex.- #NC(D)–4 Antigen-specific T-cell activation.- #E Antibodies in Relation to Oncology.- #E–1 Requirements by cancer cells for polypeptide growth factors suggest new therapeutic strategies.- #E–2 Monoclonal antibodies to human tumours for targeting cytotoxic drugs.- #E–3 Antigenic modulation as a limiting factor in the treatment of B-cell lymphoma with anti-idiotype antibody.- #E–4 Tumour-associated carbohydrate antigens of glycoproteins.- #E–5 Glycolipid antigens: potential in cancer detection and diagnosis.- #NC(E) NOTES and COMMENTS related to the foregoing topics.- #NC(E)–1 Immune surveillance.- #NC(E)–2 WORKSHOP DISCUSSION focused on #E–4, #E–5 & #E–3.- Guidance for ‘uninitiated’ readers.- Corrections to Vol. 13.